Related Experiment Video
Updated: Jan 5, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Molecular Pathogenesis of Membranous Nephropathy
1Rare and Common Kidney Diseases: From Molecular Mechanisms to Personalized Medicine Unit, INSERM UMRS 1155, Sorbonne Université, 75020 Paris, France;
Membranous nephropathy is an autoimmune kidney disease. Advances in identifying antigens like PLA2R and developing antibody assays have improved diagnosis and treatment monitoring for this condition.
Area of Science:
- Nephrology
- Immunology
- Autoimmune Diseases
Background:
- Membranous nephropathy is a noninflammatory autoimmune kidney disease.
- Characterized by immune deposits, proteinuria, and risk of renal failure.
- Advances in understanding molecular pathogenesis have identified key antigens.
Purpose of the Study:
- To summarize recent advances in understanding membranous nephropathy.
- To highlight the role of antigen identification and antibody assays.
- To underscore the need for further research in therapeutic strategies.
Main Methods:
- Identification of pathogenic antigens (e.g., PLA2R, THSD7A).
- Characterization of antibody-binding domains (epitopes).
- Development of sensitive assays for circulating antibodies.
Main Results:
- PLA2R immunization is implicated in 70-80% of adult cases.
- Specific assays have shifted diagnostic and monitoring paradigms.
- Genetic risk factors (HLA loci, PLA2R1) identified, varying by ethnicity.
Conclusions:
- Understanding of antibody pathogenicity and complement activation pathways has improved.
- Further research is crucial for developing novel therapeutic strategies.
- Identifying triggering events and molecular bases of disease progression is essential.
More Related Videos
15:04Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Nephrotic Syndrome I : Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Fluid Mosaic Model
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Intralumenal Vesicles and Multivesicular Bodies
Acute Kidney Injury II: Pathophysiology